Cover image of the article: Benefits of Metformin Combined with Insulin in Children with Type 1 Diabetes Mellitus.

Image Credit:Shiraz E-Med J

Benefits of Metformin Combined with Insulin in Children with Type 1 Diabetes Mellitus.

Authors

Z Abdeyazdan 1,*, M Hashemipour 2, R Barekatain 3, F Kalantary 4, M Amini 4
1Associate Professor, Nursing and Midwifery Care Research Center, Faculty of Nursing and Midwifery,
2Professor, Department of Pediatrics, School of Medicine,
3Pediatrician, Endocrine and Metabolism Research Center,
4Nurse, Endocrine and Metabolism Research Center, ? Professor, Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
*Corresponding Author: Nursing and Midwifery Care Research Center, Faculty of Nursing and Midwifery, Hezarjerib Ave, Isfahan, Iran, Telephone: +98(311)7922-908, abdeyazdan@nm.mui.ac.ir. Email: abdeyazdan@nm.mui.ac.ir

Shiraz E-Medical Journal:Vol. 12, issue 4; 167-71
Published online:Oct 01, 2011
Article type:Research Article
Received:Aug 10, 2010
Accepted:Aug 22, 2011
How to Cite:Abdeyazdan Z, Hashemipour M, Barekatain R, Kalantary F, Amini M. Benefits of Metformin Combined with Insulin in Children with Type 1 Diabetes Mellitus.. Shiraz E-Med J. 2011;12(4):. doi:

Abstract

Background:

Some patients with type 1 diabetes mellitus have not good glycaemic control with ordinary doses of insulin. So applying other treatment modality in addition to insulin and diet therapy could improve glycaemic control.

Objective:

To evaluate whether, in patients with type 1 diabetes mellitus, the addition of Metformin to insulin and standard diabetes management result in better glycaemic control and lower insulin dosage .

Methods:

In a clinical trial study 16 children and adolescents with type 1 diabetes with had high insulin intake and HbA1c >8% were participated. HbA1c, FBS, 2hpp BG, insulin dosage and BMI were measured and compared at the onset and end of the treatment.

Results:

There were significant differences in HbA1c and insulin dosage between the time of 0 of the study and after 4 months of Metformin addition therapy. But there were no significant differences between BMI, FBG and 2 h pp BG at the onset of the study and end of it.

Conclusion:

Metformin treatment lowered HbA1c and decreased insulin dosage in patients with type 1 diabetes in poor metabolic control. Long term studies will determine if these improvements are sustained.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

15
Feb
2014
A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus

A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus

Aria Setoodeh,
Parastoo Rostami,
Ali Rabbani,
Maryam Nakhaei-Moghadam,
Farnaz Najmi-Varzaneh,
Nima Rezaei

Setoodeh A, Rostami P, Rabbani A, Nakhaei-Moghadam M, Najmi-Varzaneh F, et al. A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus. Inn J Pediatr. 2014;24(2):. doi:

31
Jul
2021
Comparison of Insulin Glargine and Detemir Effects on Hormones of Appetite and Metabolic Control in Patients with Type 1 Diabetes: A Randomized Clinical Trial

Comparison of Insulin Glargine and Detemir Effects on Hormones of Appetite and Metabolic Control in Patients with Type 1 Diabetes: A Randomized Clinical Trial

Maryam Razzaghy-Azar,
Hosein Momeni,
Mona Nourbakhsh,
Mitra Nourbakhsh,
Atefeh Talebi,
Gholamreza Pourgholi
,et al.

Razzaghy-Azar M, Momeni H, Nourbakhsh M, Nourbakhsh M, Talebi A, et al. Comparison of Insulin Glargine and Detemir Effects on Hormones of Appetite and Metabolic Control in Patients with Type 1 Diabetes: A Randomized Clinical Trial. Iran J Pharm Res. 2021;20(3):e124482. doi: https://doi.org/10.22037/ijpr.2021.114841.15059

29
Sep
2014
Association between HbA1C value at the time of diagnosis and response rate to treatment in children with type I diabetes mellitus

Association between HbA1C value at the time of diagnosis and response rate to treatment in children with type I diabetes mellitus

Simin Gheini,
Mastooreh Hosseini,
Mansour Rezaei

Gheini S, Hosseini M, Rezaei M. Association between HbA1C value at the time of diagnosis and response rate to treatment in children with type I diabetes mellitus. J Kermanshah Univ Med Sci. 2014;18(6):e74084. doi: https://doi.org/10.22110/jkums.v18i6.1671

13
Jun
2021
Evaluation of Microalbuminuria and Glycosylated Hemoglobin in the Assessment of Diabetes Control in Children with Type 1 Diabetes Mellitus Hospitalized with Diabetic Ketoacidosis

Evaluation of Microalbuminuria and Glycosylated Hemoglobin in the Assessment of Diabetes Control in Children with Type 1 Diabetes Mellitus Hospitalized with Diabetic Ketoacidosis

Saiprasad Onkareshwar Kavthekar,
Vijay Tukaram Mali,
Sachin Verma,
Anil Bapurao Kurane,
Nivedita Balasaheb Patil,
Suhas Panditrao Kulkarni

Kavthekar SO, Mali VT, Verma S, Kurane AB, Patil NB, et al. Evaluation of Microalbuminuria and Glycosylated Hemoglobin in the Assessment of Diabetes Control in Children with Type 1 Diabetes Mellitus Hospitalized with Diabetic Ketoacidosis. J Compr Ped. 2021;12(2):e109904. doi: https://doi.org/10.5812/compreped.109904

20
Nov
2017
Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?

Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?

Ewa Otto-Buczkowska,
Natalia Jainta

Otto-Buczkowska E, Jainta N. Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?. Int J Endocrinol Metab. 2018;16(1):e13008. doi: https://doi.org/10.5812/ijem.13008

More by these authors

Z AbdeyazdanPubMedScholar
M HashemipourPubMedScholar
R BarekatainPubMedScholar
F KalantaryPubMedScholar
Share
Cited by
Metrics